← Back to Browse
ProductDiagnostic Tests

TBI assay

South Korea

Rapid blood-based assay for traumatic brain injury diagnosis using dual biomarkers (GFAP and UCH-L1) with magnetic particle immunoassay technology. Delivers results in 15-50 minutes on a fully automated platform, enabling quick and accurate detection of brain concussions and traumatic brain injuries...

Manufactured by

South Korea

VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
38 relevant products
2United States
14 relevant products
3Germany
3 relevant products
🔒

17 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 91 closest product alternatives

91 products

88 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products